PTAB Will Review Alzheimer's Treatment Patent
The Patent Trial and Appeal Board has agreed to review a Chinese company's patent involving a treatment for Alzheimer's disease challenged by biotech firm Alzheon Inc....To view the full article, register now.
Already a subscriber? Click here to view full article